Two major outer envelope glycoproteins of Epstein-Barr virus are encoded by the same gene.
about
CD19, the earliest differentiation antigen of the B cell lineage, bears three extracellular immunoglobulin-like domains and an Epstein-Barr virus-related cytoplasmic tailDistinctive charge configurations in proteins of the Epstein-Barr virus and possible functions.Epstein-Barr virus recombinant lacking expression of glycoprotein gp150 infects B cells normally but is enhanced for infection of epithelial cells.Epstein-Barr virus small nuclear RNAs are not expressed in permissively infected cells in AIDS-associated leukoplakiaMolecular basis of the interaction between complement receptor type 2 (CR2/CD21) and Epstein-Barr virus glycoprotein gp350.Human antibody titers to Epstein-Barr Virus (EBV) gp350 correlate with neutralization of infectivity better than antibody titers to EBV gp42 using a rapid flow cytometry-based EBV neutralization assayVaricella-zoster virus as a live vector for the expression of foreign genes.Epstein-Barr virus mRNAs produced by alternative splicingInfection of primary CD4+ and CD8+ T lymphocytes by Epstein-Barr virus enhances human immunodeficiency virus expression.Epstein-Barr virus entry.The analysis of EBV proteins which are antigenic in vivo.The Epstein-Barr virus lytic program is controlled by the co-operative functions of two transactivators.An Epstein-Barr virus transcription unit is at least 84 kilobases long.DNA sequence of the herpes simplex virus type 1 gene encoding glycoprotein gH, and identification of homologues in the genomes of varicella-zoster virus and Epstein-Barr virus.The Epstein-Barr virus (EBV) BZLF1 immediate-early gene product differentially affects latent versus productive EBV promoters.Four phosphoproteins with common amino termini are encoded by human cytomegalovirus AD169.The Epstein-Barr virus immediate-early gene product, BMLF1, acts in trans by a posttranscriptional mechanism which is reporter gene dependent.Identification of the Epstein-Barr virus gp85 gene.Induction of antibodies to the Epstein-Barr virus glycoprotein gp85 with a synthetic peptide corresponding to a sequence in the BXLF2 open reading frame.A monoclonal antibody to glycoprotein gp85 inhibits fusion but not attachment of Epstein-Barr virus.Soluble gp350/220 and deletion mutant glycoproteins block Epstein-Barr virus adsorption to lymphocytes.Inhibition of Epstein-Barr virus (EBV) release from P3HR-1 and B95-8 cell lines by monoclonal antibodies to EBV membrane antigen gp350/220.Epstein-Barr virus glycoprotein homologous to herpes simplex virus gB.Expression of the Epstein-Barr virus gp350/220 gene in rodent and primate cellsCharacterization of herpesvirus sylvilagus glycoproteins released into the culture medium of infected cells: antisera to gp13 and gp32 neutralize viral infectivity in vitro and identify antigens on plasma membranes of infected cellsEBV-positive human sera contain antibodies against the EBV BMRF-2 protein.Infection of human B lymphocytes with lymphocryptoviruses related to Epstein-Barr virusMapping of B-cell epitopes on the polypeptide chain of the Epstein-Barr virus major envelope glycoprotein and candidate vaccine molecule gp340.Identification of two T-cell epitopes on the candidate Epstein-Barr virus vaccine glycoprotein gp340 recognized by CD4+ T-cell clones.The 5' splice site: phylogenetic evolution and variable geometry of association with U1RNA.Antibody limits in vivo murid herpesvirus-4 replication by IgG Fc receptor-dependent functions.Recombinant vaccinia virus induces neutralising antibodies in rabbits against Epstein-Barr virus membrane antigen gp340.Concept and application of a computational vaccinology workflow.
P2860
Q24682415-B77816F8-3D17-4004-9889-488D8DA0EFD5Q33646566-E6BFB4FA-0A4D-4A00-A1D7-C98C46341C2BQ33784012-84FE2353-5BE9-4013-80FA-E4C8EDD3FA12Q33891606-9148EEE6-2E6F-42D3-931B-9F30BC5561A0Q34597080-75077D65-CC11-489D-BCA7-465679138036Q34609654-37838E1D-3F57-42C1-8F9E-A7CC68CAB007Q34629086-33FD4712-EE4A-452B-971D-63DE1B7A7106Q35051384-FAE81249-5408-4CC8-ACA8-ADD1C5FEC102Q35871457-0FEA2D4D-774D-45FD-B91D-450FD9D81985Q35947541-2825C329-57FC-402B-96E1-569CEDCC411EQ35999054-9185D67E-0045-44DE-A396-1544DA6793E0Q36079854-FEA8DB7A-C4D0-4007-AA69-74F0950C2476Q36095360-196D751B-9F04-4AC1-8141-ACFD45218FC5Q36099945-06E8D5AE-EC00-4E08-9443-779E2EECD79CQ36792029-99682B13-1F7C-402F-A2C9-A4A62F1B5A50Q36826580-50E0B7FD-AE78-4368-A937-1EDD0A1FC574Q36830488-832579F0-AD1C-4CEA-B210-D1FC9188C829Q36865571-046EE826-6FBA-463C-A83F-68D099DBE221Q36865623-5F49D4D6-E49B-484E-956B-0C5EFAF23737Q36871887-8270DCD9-1E68-4691-BDE4-2E52898DC027Q36873321-8A9E6C5D-4466-4060-B026-7FF988A8AD73Q36877989-ED85D616-AF63-4D13-9BD4-FBAD1B4F923EQ36884762-05DE911A-1C7F-4905-8A6F-16C02700715DQ36888549-A3208F4B-6B67-49AC-BF11-F2A8416AB0A8Q36919666-C9A1BF00-4D7A-4255-AEC5-0D9091A2F768Q37408295-26859FB2-31F2-4DE5-A3F5-214E5F6477B3Q39579306-30767BB2-553A-457E-9880-E68B3AAB5B52Q40064225-ADBF5560-B926-45AA-ADB9-46781DCA8D93Q40067251-6E32D7C7-359B-49D9-AFF3-161713740B2BQ40448133-6C55A65A-2C9E-45CC-8EB0-BAD903C54D14Q41040271-200CB147-A5AD-46DA-860C-93000CB7F51AQ41430227-18C59BC2-7926-4EF0-841B-900C3B30E949Q41848439-D6B72AAF-9346-4AB2-8491-1148722CAE88
P2860
Two major outer envelope glycoproteins of Epstein-Barr virus are encoded by the same gene.
description
1985 nî lūn-bûn
@nan
1985年の論文
@ja
1985年論文
@yue
1985年論文
@zh-hant
1985年論文
@zh-hk
1985年論文
@zh-mo
1985年論文
@zh-tw
1985年论文
@wuu
1985年论文
@zh
1985年论文
@zh-cn
name
Two major outer envelope glyco ...... are encoded by the same gene.
@en
type
label
Two major outer envelope glyco ...... are encoded by the same gene.
@en
prefLabel
Two major outer envelope glyco ...... are encoded by the same gene.
@en
P2093
P2860
P1433
P1476
Two major outer envelope glyco ...... are encoded by the same gene.
@en
P2093
P2860
P304
P407
P577
1985-06-01T00:00:00Z